Jornada Seguridad del Paciente 2024
IR A LA WEB DE LA JORNADA

IR A LA WEB DE LA JORNADA
Seminario Virtual – 2ª Convocatoria Calendario de Vacunaciones de Andalucía. Novedades Mayo 2024. — 28 de mayo – 17:00horas — No conlleva certificado de asistencia o participación. Web de Andavac VER 2º SEMINARIOVER 1ER SEMINARIO
I Jornada de Protección de la Salud Escuela Andaluza de Salud Pública 23 de mayo de 2024 DESCARGAR PROGRAMAVER FOTOS Y NOTICIAS VER JORNADAVER JORNADA
#CáncerCabeza-CuelloJornada PRESENCIAL Y VIRTUAL Derivación temprana y Detección Precoz del Cáncer de Cabeza y Cuello en Andalucía Coordinación Científica Dr. Antonio Rueda Domínguez. Jefe de Servicio de Oncología Médica. Hospital Regional Universitario de Málaga. Dra. Maria José Sánchez Pérez. Profesora de la Escuela Andaluza de Salud Pública. Directora del Registro de Cáncer de Granada.…
Seminario Virtual Calendario de Vacunaciones de Andalucía. Novedades Mayo 2024. — 21 de mayo – 17:00horas — No precisa inscripción, no conlleva certificado de asistencia o participación. Web de Andavac Acceso a la grabación del Seminario
Advancing equity through Health Impact Assessments. Guide for the EuroHealthNet Partnership on conducting and implementing Health Impact Assessments with an equity focus. The Guide has been developed with and for the EuroHealthNet Partnership, through an online survey as well as interviews, supplemented by desk research. The input received was central to the development of this…
Background Management of lymphoid malignancies requires substantial health system resources. Total national health expenditure might influence population-based lymphoid malignancy survival. We studied the long-term survival of patients with 12 lymphoid malignancy types and examined whether different levels of national health expenditure might explain differences in lymphoid malignancy prognosis between European countries and regions. Methods For…
Methods We conducted a narrative review to explore and describe alternatives for equitable vaccine access in Latin America. We searched and considered the main access strategies reported in the literature through PubMed, Science Direct, and Google Scholar. Additionally, we reviewed the web sites of key stakeholders. The search was conducted using the following keywords: (“access”…
Introduction Abemaciclib is an oral inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). Data from the clinical trial monarchE (2023) showed improved survival from invasive disease. The aim of the present article was to conduct an economic assessment of adjuvant treatment with abemaciclib in women with luminal, HER2- and node-positive breast cancer. Methods A Markov…
Introduction Recent data are not available on ongoing CPR for emergency services with an onboard physician. The aim of the present study was to identify factors associated with the decision to transport patients to hospital with ongoing CPR and examine their survival to hospital discharge with good neurological status. Methods An observational study based on…